Yesterday, the U.S. Supreme Court ruled that huge cuts in 340B hospitals’ Medicare Part B drug reimbursement in 2018 and 2019 were unlawful. It marked the end of Phase 1 of the debate over the cuts.
Phase 2 is gearing up. It will be played out in a federal appeals court in Washington, D.C., a federal district court in Washington, and the pages of the Federal Register.
Phase 2 of the debate over huge cuts in 340B hospitals’ Medicare Part B drug reimbursement is gearing up. It will be played out in a federal appeals court in Washington, D.C., a federal district court in Washington, and the pages of the Federal Register.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
